alexa High Density Lipoproteins: The Good, The Bad And The Not So Ugly
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

5th World Congress on Diabetes & Metabolism
November 03-05, 2014 Embassy Suites Las Vegas, USA

Jane McEneny
ScientificTracks Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156.S1.026
High density lipoproteins (HDL) display many cardio-protective properties, including their involvement in reverse cholesterol transport, their ability to lower inflammation and function as antioxidants. However, these cardio-protective properties may be diminished in the presence of chronic inflammation, as occurs in certain conditions/diseases, which include obesity, polycystic ovarian syndrome, diabetes and cardiovascular disease. Under conditions of increased inflammation the inflammatory marker serum amyloid A is released into the circulation, where it rapidly associates with HDL and hinders or negates the cardioprotective properties of this lipoprotein. Therefore, diets that may enhance inflammation, such as ones rich in saturated fatty acids may augment SAA release, while ones rich in naturally occurring antioxidants, including lycopene, lutein, zeaxanthin and beta-cryptoxanthin may hinder or prevent its release. Therefore, this study will examine the role of diet and how this may influence the anti-atherogenic properties of HDL. It will also assess if SAA is a superior molecule to identify increased inflammation, compared to other more widely cited inflammatory molecules including C-reactive protein and the interleukins.
Jane McEneny obtained her PhD from Queen?s University, Belfast, UK and is currently a senior lecture in the Centre for Public Health, also at Queen?s University Belfast, UK. McEneny has authored 75 papers, is on the editorial board of several journals, and is a reviewer for several eminent journals and granting bodies. Currently, McEneny?s main focus of research is the role of inflammation and how this influences the anti-atherogenic properties of high density lipoproteins. The main subject populations under investigation include those with characteristics of the metabolic syndrome, diabetes and known cardiovascular disease.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version